Dynamics of acylcarnitines, hypoglycin A, méthylènecyclopropylglycine and their metabolites in a Kladruber stallion with atypical myopathy

References

• AlzbetaG. AlzbetaG/Metabol: First version 2019 May 30. [accessed 2022 Jul 1]. https://zenodo.org/record/3235775.
   Google Scholar
• Bochnia M, Sander J, Ziegler J, Terhardt M, Sander S, Janzen N, Cavalleri J-MV, Zuraw A, Wensch-Dorendorf M, Zeyner A, et al. 2019. Detection of MCPG metabolites in horses with atypical myopathy. PLoS One. 14(2):e0211698.
   PubMed Web of Science ®Google Scholar
• Bochnia M, Scheidemann W, Ziegler J, Sander J, Vollstedt S, Glatter M, Janzen N, Terhardt M, Zeyner A. 2018. Predictive value of hypoglycin A and methylencyclopropylacetic acid conjugates in a horse with atypical myopathy in comparison to its cograzing partners. Equine Vet Educ. 30(1):24–28.
   Web of Science ®Google Scholar
• Bochnia M, Ziegler J, Sander J, Uhlig A, Schaefer S, Vollstedt S, Glatter M, Abel S, Recknagel S, Schusser GF, et al. 2015. Hypoglycin A content in blood and urine discriminates horses with atypical myopathy from clinically normal horses grazing on the same pasture. PLoS ONE. 10(9):e0136785.
   PubMed Web of Science ®Google Scholar
• Boemer F, Detilleux J, Cello C, Amory H, Marcillaud-Pitel C, Richard E, van Galen G, van Loon G, Lefère L, Votion D-M, et al. 2017. Acylcarnitines profile best predicts survival in horses with atypical myopathy. PLoS One. 12(8):e0182761.
   PubMed Web of Science ®Google Scholar
• Carlier J, Guitton J, Moreau C, Boyer B, Bévalot F, Fanton L, Habyarimana J, Gault G, Gaillard Y. 2015. A validated method for quantifying hypoglycin A in whole blood by UHPLC-HRMS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 978–979:70–77.
   PubMed Web of Science ®Google Scholar
• Dunkel B, Ryan A, Haggett E, Knowles EJ. 2020. Atypical myopathy in the South‐East of England: clinicopathological data and outcome in hospitalised horses. Equine Vet Educ. 32(2):90–95.
   Web of Science ®Google Scholar
• Fabius LS, Westermann CM. 2018. Evidence-based therapy for atypical myopathy in horses. Equine Vet Educ. 30(11):616–622.
   Web of Science ®Google Scholar
• Finno CJ, Valberg SJ, Wünschmann A, Murphy MJ. 2006. Seasonal pasture myopathy in horses in the midwestern United States: 14 cases (1998–2005). J Am Vet Med Assoc. 229(7):1134–1141.
   PubMed Web of Science ®Google Scholar
• González-Medina S, Ireland JL, Piercy RJ, Newton JR, Votion DM. 2017. Equine atypical myopathy in the UK: Epidemiological characteristics of cases reported from 2011 to 2015 and factors associated with survival. Equine Vet J. 49(6):746–752.
   PubMed Web of Science ®Google Scholar
• Gröndahl G, Berglund A, Skidell J, Bondesson U, Salomonsson M. 2015. Clinical research abstracts of the British Equine Veterinary Association Congress 2015. Equine Vet J. 47(Suppl 48):22.
   PubMedGoogle Scholar
• Karlíková R, Široká J, Jahn P, Friedecký D, Gardlo A, Janečková H, Hrdinová F, Drábková Z, Adam T. 2016. Equine atypical myopathy: a metabolic study. Vet J. 216:125–132.
   PubMed Web of Science ®Google Scholar
• Karlíková R, Široká J, Mech M, Friedecký D, Janečková H, Mádrová L, Hrdinová F, Drábková Z, Dobešová O, Adam T, et al. 2018. Newborn foal with atypical myopathy. J Vet Intern Med. 32(5):1768–1772.
   PubMed Web of Science ®Google Scholar
• Luís PBM, Ruiter JPN, Ijlst L, Tavares de Almeida I, Duran M, Mohsen A-W, Vockley J, Wanders RJA, Silva MFB. 2011. Role of isovaleryl-CoA dehydrogenase and short branched-chain acyl-CoA dehydrogenase in the metabolism of valproic acid: implications for the branched-chain amino acid oxidation pathway. Drug Metab Dispos. 39(7):1155–1160.
   PubMed Web of Science ®Google Scholar
• Mathis D, Sass JO, Graubner C, Schoster A. 2021. Diagnosis of atypical myopathy based on organic acid and acylcarnitine profiles and evolution of biomarkers in surviving horses. Mol Genet Metab Rep. 29:100827.
   PubMed Web of Science ®Google Scholar
• Sander J, Cavalleri J-MV, Terhardt M, Bochnia M, Zeyner A, Zuraw A, Sander S, Peter M, Janzen N. 2016. Rapid diagnosis of hypoglycin A intoxication in atypical myopathy of horses. J Vet Diagn Invest. 28(2):98–104.
   PubMed Web of Science ®Google Scholar
• Sander J, Terhardt M, Janzen N. 2020. Study on the metabolic effects of repeated consumption of canned ackee. J Agric Food Chem. 68(49):14603–14609.
   PubMed Web of Science ®Google Scholar
• Sander J, Terhardt M, Sander S, Janzen N. 2018. Use of a standard newborn screening test for the rapid diagnosis of inhibited ß-oxidation in atypical myopathy in horses. J Equine Vet Sci. 67:71–74.
   Web of Science ®Google Scholar
• Sponseller BT, Valberg SJ, Schultz NE, Bedford H, Wong DM, Kersh K, Shelton GD. 2012. Equine multiple acyl-CoA dehydrogenase deficiency (MADD) associated with seasonal pasture myopathy in the midwestern United States. J Vet Intern Med. 26(4):1012–1018.
   PubMed Web of Science ®Google Scholar
• Toutain PL, Lassourd V, Costes G, Alvinerie M, Bret L, Lefebvre HP, Braun JP. 1995. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses. J Vet Pharmacol Ther. 18(3):226–235.
   PubMed Web of Science ®Google Scholar
• Valberg SJ, Sponseller BT, Hegeman AD, Earing J, Bender JB, Martinson KL, Patterson SE, Sweetman L. 2013. Seasonal pasture myopathy/atypical myopathy in North America associated with ingestion of hypoglycin A within seeds of the box elder tree. Equine Vet J. 45(4):419–426.
   PubMed Web of Science ®Google Scholar
• Van Galen G, Amory H, Busschers E, Cassart D, De Bruijn M, Gerber V, Keen J, Lefere L, Pitel CM, Marr C, et al. 2010. European outbreak of atypical myopathy in the autumn 2009. J Vet Emerg Crit Care (San Antonio). 20(5):528–532.
   PubMed Web of Science ®Google Scholar
• van Galen G, Marcillaud Pitel C, Saegerman C, Patarin F, Amory H, Baily JD, Cassart D, Gerber V, Hahn C, Harris P, et al. 2012. European outbreaks of atypical myopathy in grazing equids (2006–2009): spatiotemporal distribution, history and clinical features. Equine Vet J. 44(5):614–620.
   PubMed Web of Science ®Google Scholar
• van Galen G, Saegerman C, Marcillaud Pitel C, Patarin F, Amory H, Baily JD, Cassart D, Gerber V, Hahn C, Harris P, et al. 2012. European outbreaks of atypical myopathy in grazing horses (2006–2009): determination of indicators for risk and prognostic factors. Equine Vet J. 44(5):621–625.
   PubMed Web of Science ®Google Scholar
• Votion D-M, Linden A, Saegerman C, Engels P, Erpicum M, Thiry E, Delguste C, Rouxhet S, Demoulin V, Navet R, et al. 2007. History and clinical features of atypical myopathy in horses in Belgium (2000–2005). J Vet Intern Med. 21(6):1380–1391.
   PubMed Web of Science ®Google Scholar
• Votion DM, Serteyn D. 2008. Equine atypical myopathy: a review. Vet J. 178(2):185–190.
   PubMed Web of Science ®Google Scholar
• Votion D-M, van Galen G, Sweetman L, Boemer F, de Tullio P, Dopagne C, Lefère L, Mouithys-Mickalad A, Patarin F, Rouxhet S, et al. 2014. Identification of methylenecyclopropyl acetic acid in serum of European horses with atypical myopathy. Equine Vet J. 46(2):146–149.
   PubMed Web of Science ®Google Scholar
• Westermann CM, Dorland L, Votion DM, de Sain-van der Velden MGM, Wijnberg ID, Wanders RJA, Spliet WGM, Testerink N, Berger R, Ruiter JPN, et al. 2008. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy. Neuromuscul Disord. 18(5):355–364.
   PubMed Web of Science ®Google Scholar
• Witkowska-Pilaszewicz O, Kaszak I, Zmigrodska M, Winnicka A, Sacharczuk M, Szczepaniak J, Cywinska A. 2019. Equine Atypical myopathy – a review. Anim Sci Pap Rep. 37(3):233–242.
   Web of Science ®Google Scholar